Five things for pharma marketers to know: Friday, February 23, 2018

Share this content:

Pharma is spending much of its tax savings on share-buyback programs. Nine drug companies, including AbbVie, Pfizer, Merck, and Amgen, are spending a collective $50 billion to buy back shares. The move could raise stock prices and become a boon to institutional investors and executives. (Axios)

Facebook's latest algorithm change is creating an opportunity for healthcare marketers to use patient influencers. The social media giant began prioritizing content from people over brands, which means posts from influencers carry added value, according to a white paper from WEGO Health. (MM&M)

President Donald Trump has claimed his new Health and Human Services secretary has already lowered drug prices. However, statistics show Alex Azar hasn't moved the needle yet, though he has indicated it is a top priority. (STAT)

Bristol-Myers Squibb will cut 107 employees from its research and development facility in Wallingford, Connecticut. The pharma company has already halved the workforce at the site to 400 staffers. (Endpoints)  

An ad that lets viewers experience the slopes from the perspective of a visually impaired paralympic skier is getting rave reviews. The Instagram ad, which was part of Toyota's “Start Your Impossible” campaign, features Menna Fitzpatrick, an 18-year-old Paralympic alpine skier who contracted an eye infection when she was a year old, resulting in the loss of most of her vision. (Adweek)
Share this content:
Scroll down to see the next article